AMNOG was the end of paradise for pharmaceutical companies, correct Prof. Hammerschmidt?
What have been the main changes after 10 years of AMNOG for pharmaceutical companies? What have been the biggest successes [...]
Prof. Dr. Juergen Wasem – What happens, when negotiations fail?
Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the [...]
Bibiane Schulte-Bosse – How to fight well in AMNOG negotiations.
In this Podcast episode, Dr. Stefan Walzer is explaining the details of the price negotiations within the AMNOG process together [...]
Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement specifics including [...]
Dr. Mathias Flume – AMNOG will change in 2022, but how?
In this Podcast episode, Dr. Stefan Walzer is talking with Dr. Mathias Flume about the AMNOG process as well as [...]
Advertisement
